Results of Surgical Treatment of Rheumatic Tricuspid Valve Disease Combined with Mitral and Aortic Valvular Disease in 380 Patients

张宝仁,郝家骅,朱家麟,徐志云,梅举,邹良建
DOI: https://doi.org/10.3760/cma.j.issn.1001-4497.1999.02.002
1999-01-01
Abstract:Aim:To evaluate the clinical outcome of surgical interventions of combined mitral,aortic and tricuspid valvular lesions with rheumatic etiology.Clinical material and method:Three hundred and eighty patients with combined mitral,aortic and tricuspid valvular lesions were treated surgically from 1990 to 1998.Among them,346 patients had rheumatic mitral and aortic valve lesions associated with functional tricuspid regurgitation and rheumatic fever involving the triple valves in 34.The heart function was class III to IV in 95.4% of patients(NYHA).Mitral valve and aortic replacements were performed in all patients.DeVega or Kay annuloplasty was carried out in patients with functional tricuspid regurgitation.Commissurotomy and DeVega annuloplasty were performed in those with organic tricuspid stenosis.Results:There were 39 early operative deaths with a mortality rate of 10.26%.During the recent four years,the operative mortality rate was significantly reduced to 2.10%.The mean follow up was 4.4 patient·years.Five year survival rate was 80.72%.Conclusion:The patients with rheumatic triple valvular diseases are often associated with both left and right ventricular dysfunction,pulmonary hypertension and systemic venous stasis which further lead to obvious dysfunction of the other vital organs.Therefore,the proper perioperative management and carefully correction of tricuspid regurgitation with annuloplasty are important factors influencing surgical results.
What problem does this paper attempt to address?